Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluating Silymarin for Chronic Hepatitis C
NCT00030030Phase 2Completed
- Sponsor
- National Center for Complementary and Integrative Health
- Start
- Jul 2000
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of silymarin in hepatitis C (HCV) (2 arms), sponsored by National Center for Complementary and Integrative Health. Started Jul 2000; status: completed.
02
Drugs
silymarin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00030030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00030030.